Hiroyuki Tanaka

Active 1988–2025

264
Papers
29,504
Citations
94
h-index
227
i10-index

Citations

Citations per year for Hiroyuki Tanaka1978: 1 citations1989: 1 citations1994: 4 citations1995: 3 citations1996: 13 citations1997: 18 citations1998: 26 citations1999: 14 citations2000: 37 citations2001: 67 citations2002: 90 citations2003: 98 citations2004: 135 citations2005: 120 citations2006: 153 citations2007: 199 citations2008: 148 citations2009: 159 citations2010: 180 citations2011: 196 citations2012: 196 citations2013: 216 citations2014: 209 citations2015: 238 citations2016: 211 citations2017: 228 citations2018: 239 citations2019: 574 citations2020: 666 citations2021: 644 citations2022: 611 citations2023: 385 citations2024: 675 citations2025: 273 citations2026: 7 citations1979–1988: no citations, so these years are not shown1990–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,916 citing papers, 19.5% of this breakdownJapan: 1,149 citing papers, 11.7% of this breakdownChina: 1,067 citing papers, 10.9% of this breakdownUnited Kingdom: 575 citing papers, 5.8% of this breakdownGermany: 461 citing papers, 4.7% of this breakdownItaly: 434 citing papers, 4.4% of this breakdownCanada: 322 citing papers, 3.3% of this breakdownFrance: 296 citing papers, 3% of this breakdownSouth Korea: 272 citing papers, 2.8% of this breakdownAustralia: 216 citing papers, 2.2% of this breakdownNetherlands: 211 citing papers, 2.1% of this breakdownIndia: 202 citing papers, 2.1% of this breakdown
0%19.5%Other 27.5%

Fields

  • Medicine51.7%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Engineering8.1%
  • Immunology and Microbiology7.1%
  • Agricultural and Biological Sciences3.5%
  • Neuroscience3%
  • Other9.3%

Topics

  • Coronary Interventions and Diagnostics2%
  • Asthma and respiratory diseases1.8%
  • Immune Response and Inflammation1.6%
  • Organic Light-Emitting Diodes Research1.5%
  • Parathyroid Disorders and Treatments1.3%
  • Luminescence and Fluorescent Materials1.2%
  • Other90.6%

Coauthors

All papers

Open in search
  1. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshihisa Nakagawa, Takeshi Kimura, STOPDAPT-2 ACS Investigators, Ken Kozuma, Keiichi Igarashi Hanaoka, Saori Tezuka, Yumika Fujino, Risa Kato, Masayo Kitamura, Miyuki Tsumori, Miya Hanazawa, Misato Yamauchi, Itsuki Yamazaki, Mitsugu Hirokami, Nobuko Makiguchi, Yoichi Nozaki, Hirofumi Tomita, Masahiro Yagi, Tatsuya Komaru, Motoaki Higuchi, Takaaki Isshiki, Takahide Kodama, Atsushi Tosaka, Itaru Takamisawa, Hiroyuki Tanaka, Yoshiki Hata, Ryuichi Kato, Yoshihiro J. Akashi, Kazuhiko Yumoto, Kengo Tsukahara, Junya Ako, Y Onishi, Hiroyasu Uzui, Toshiyuki Noda, Itsuo Morishima, Minoru Yamada, Ruka Yoshida, Susumu Suzuki, Takuya Maeda, Takashi Tanigawa, Kazuaki Kaitani, Shunzo Matsuoka, Masaharu Akao, Takafumi Yokomatsu, Moriaki Inoko, Tsukasa Inada, Takashi Morita, Gaku Nakazawa, Shozo Ishihara, Makoto Kinoshita, Takanori Kusuyama, Kiyonori Togi, Toshihiro Tamura, Takashi Akasaka, Isao Tabuchi, Yasuki Kihara, Hironori Ueda, Yusuke Katayama, Takatoshi Wakeyama, Takeo Kaneko, Tetsuzo Wakatsuki, Koichi Kishi, Masayuki Doi, Hideki Okayama, Nobuhiro Suematsu, Shujiro Inoue, Masahiro Natsuaki, Kenichi Tsujita, Tomohiro Sakamoto, Hirofumi Kurokawa and 2 more - JAMA Cardiology 2022 cited by 300

  2. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites

    Authors: , , , , , , - Journal of Natural Medicines 2017 cited by 594

  3. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 cited by 367

  4. JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yutaka Okita, Takeshi Kimura, Yoshiki Sawa, Kiyoshi Yoshida, on behalf of the Japanese Circulation Society Joint Working Group - Circulation Journal 2020 cited by 355

  5. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2018 cited by 340

  6. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 1,102

  7. Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes

    Authors: , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2011 cited by 883

  8. Artificial intelligence to diagnosis distal radius fracture using biplane plain X-rays

    Authors: , , , , , - Journal of Orthopaedic Surgery and Research 2021 cited by 45

  9. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2006 cited by 662

  10. Non-Driving Related tasks and journey types for future autonomous vehicle owners

    Authors: , , , , - Transportation Research Part F Traffic Psychology and Behaviour 2022 cited by 45

  11. Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitsunori Kamigaki, Hirofumi Tomita, Kenji Hanada, Motoi Kushibiki, Akihiro Nakamura, Yoshihiro Morino, Takahito Nasu, Satoshi Yasuda, Hideaki Suzuki, Kaoru Iwabuchi, Kanako Tsuji, Shigeto Namiuchi, Tatsuya Komaru, Masahiro Yagi, Shoko Uematsu, Toshiaki Takahashi, Satoru Takeda, Toru Nakanishi, Masafumi Watanabe, Masahiro Wanezaki, Motoyuki Matsui, Shigeo Sugawara, Yasuchika Takeishi, Masayoshi Oikawa, Nobuo Komatsu, Satoshi Suzuki, Hiroshi Okamoto, Noriyuki Takeyasu, Daiki Akiyama, Yutaka Eki, Tsunekazu Kakuta, Tomoyo Sugiyama, Tomomi Koizumi, Koji Ueno, Kazuomi Kario, Mizuri Taki, Yuri Matsumoto, Takanori Yasu, Osamu Nishioka, Shigeto Naito, Makoto Murata, Shoichi Tange, Katsumi Kaneko, Makoto Muto, Hiroshi Inagaki, Shuichi Hasegawa, Eizo Tachibana, Wataru Atsumi, Masahiro Suzuki, Toshihiro Muramatsu, Yoshihiro Yamada, Isao Taguchi, Yoshiaki Fukuda, Akihiro Matsui, Junji Kanda, Koji Hozawa, Akihiko Matsumura, Wataru Shimizu, Takeshi Yamamoto, Issei Komuro, Masaru Hatano, Takanori Ikeda, Shunsuke Kiuchi, Taishiro Chikamori, Yasuyoshi Takei, Kyoko Soejima, Toshinori Minamishima, Hiroyuki Tanaka, Shigeo Shimizu, Masashi Kasao and 259 more - Circulation 2022 cited by 59

  12. Efficient blue organic light-emitting diodes employing thermally activated delayed fluorescence

    Authors: , , , , , - Nature Photonics 2014 cited by 2,425

  13. Light Controls Protein Localization through Phytochrome-Mediated Alternative Promoter Selection

    Authors: , , , , , , , , , , , , - Cell 2017 cited by 163

  14. IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice

    Authors: , , , , , , , , , - Scientific Reports 2017 cited by 103

  15. Clinical Characteristics of Hospitalized Heart Failure Patients with Preserved, Mid-Range, and Reduced Ejection Fractions in Japan

    Authors: , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2019 cited by 123

  16. Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules

    Authors: , , , , , , , , , , , - EuroIntervention 2022 cited by 33

  17. Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads*

    Authors: , , , , , - Endocrinology 2000 cited by 521

  18. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

    Authors: , , , , , , , , , , , , , - European Heart Journal 2017 cited by 131

  19. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2021 cited by 72

  20. Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , - Oncology 2021 cited by 43

  21. High-efficiency organic light-emitting diodes with fluorescent emitters

    Authors: , , , , , , , , , - Nature Communications 2014 cited by 1,183

  22. Prostaglandin D 2 as a Mediator of Allergic Asthma

    Authors: , , , , , , , , , , , , , , , , , - Science 2000 cited by 740

  23. Effectiveness of Paclitaxel-Eluting Balloon Catheter in Patients With Sirolimus-Eluting Stent Restenosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2011 cited by 281

  24. Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , - Advances in Therapy 2016 cited by 141